ArticleIJID regions2025
COVID-19 pandemic reclassification and implications for continuing uptake of COVID-19 vaccination: The case of Savannah Region, Ghana, 2023.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Objectives: This study assessed the willingness of Ghanaians to accept COVID-19 vaccination following the pandemic reclassification. The findings are envisaged to facilitate implementation of contextual strategies to sustain the COVID-19 vaccination drive and avert case surges. Methods: A cross-sectional study was conducted in three districts (North Gonja, Sawla-Tuna-Kalba, and West Gonja) of the Savannah Region using an electronic questionnaire to interview respondents on willingness to accept COVID-19 vaccinations following the pandemic reclassification. Bivariate and multivariate logistic regression analysis were performed to identify factors associated with continuing COVID-19 vaccination uptake. Results: Respondents who would advocate for COVID-19 vaccination were more likely to accept it (adjusted odds ratio [AOR] = 8.4; 95% confidence interval [CI]: 6.18-11.41). Residing in an urban community (AOR = 0.78; 95% CI: 0.65-0.83) or having secondary education (AOR = 0.64; 95% CI: 0.46-0.89) was associated with reduced odds of COVID-19 vaccination acceptance. Conclusions: The willingness to accept COVID-19 vaccination was high among the respondents, and the majority would encourage their neighbors to receive vaccination. However, targeted approaches are required to address vaccine hesitancy among specific subpopulations, including urban communities and those with secondary-level education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.